IltefatHHamzaviMD

Dermatology • Canton, MI

Dermatologic Surgery

Physician Hamzavi/Dermatology specialists and Henry Ford Hospital

Join to view full profile

Dr. Hamzavi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hamzavi's full profile

Already have an account?

Office
361 N Canton Center Rd
Canton, MI 48187
Phone+1 734-495-1506

Fax+1 734-495-1780
Is this information wrong?

Summary

Dr. Iltefat Hamzavi is a dermatologist in Canton,Detroit and Fort Gratiot, MI and is affiliated with multiple hospitals in the area, including Henry Ford Hospital,McLaren Port Huron, St. Joseph Mercy Ann Arbor, Lake Huron Medical Center, and Beaumont Hospital, Wayne. He received his medical degree from University of Michigan Medical School and has been in practice 21 years. He is experienced in general dermatology, photomedicine,Vitiligo,Hidradenitis Suppurativa, and complex medical dermatology.

Education & Training

University of British ColumbiaFellowship, Photomedicine and Lasers, 2000 - 2001
Wayne State University School of MedicineResidency, Dermatology, 1997 - 2000
St Joseph Mercy Ann ArborInternship, Internal Medicine, 1996 - 1997
University of Michigan Medical SchoolClass of 1996

Certifications & Licensure

MI State Medical License 2000 - 2025
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Best Doctors Best Doctors
Top Docs Hours magazine
Super Doctor SuperDoctors.com
Fellow (FASDS) American Society for Dermatologic Surgery
Fellow (FAAD) American Academy of Dermatology
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo Start of enrollment: 2006 Jan 01
Completed
Not Applicable
Impact of Long Wavelength Ultraviolet (UVA) and Visible Light on Melanocompetent Skin Start of enrollment: 2007 May 01
Completed
Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa Start of enrollment: 2007 Jun 01
Completed
Not Applicable
Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy Start of enrollment: 2008 May 01
Completed
NdYag Laser for Acne Keloidalis Nuchae Start of enrollment: 2008 Sep 01
Unknown status
Not Applicable
Vitiligo Skin Transplantation Start of enrollment: 2009 Jan 01
Completed
Phase 3
Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa Start of enrollment: 2010 Feb 01
Completed
Not Applicable
Case-control Study on Matrix Metalloproteinase Levels in Tissue in Patients With Keloid Scar Start of enrollment: 2010 Feb 01
Completed
Not Applicable
Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia Start of enrollment: 2009 Feb 01
Completed
Treatment of Vitiligo With Low-energy Visible Light Laser Start of enrollment: 2010 Oct 01
Terminated
Not Applicable
NB-UVB and PUVA Vitiligo Study Start of enrollment: 2013 Mar 01
Completed
Phase 4
Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED) Start of enrollment: 2012 May 01
Withdrawn
Not Applicable
An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa. Start of enrollment: 2013 Jan 05
Completed
Not Applicable
Comparative Study Using Dermabrasion vs CO2 Laser & Collagen Dressing vs Vaseline Gauze in MKTP Start of enrollment: 2014 Jan 01
Unknown status
Not Applicable
Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing Start of enrollment: 2015 Jan 14
Completed
Not Applicable
An In Vivo Model for Postinflammatory Hyperpigmentation Start of enrollment: 2016 Feb 14
Completed
Not Applicable
The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects Start of enrollment: 2018 Mar 13
Completed
Not Applicable
Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects Start of enrollment: 2019 Nov 05
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Estimating the burden of vitiligo: a systematic review and modelling study.
Jennifer Akl, Solam Lee, Hyun Jeong Ju, Rosa Parisi, Ji Yoon Kim, Jae Joon Jeon, Yeon-Woo Heo, Viktoria Eleftheriadou, Iltefat Hamzavi, Christopher E M Griffiths, Darr...> ;The Lancet. Public Health. 2024 Mar 26
Integrating skin color assessments into clinical practice and research: A review of current approaches.
Valerie M Harvey, Andrew Alexis, Chidubem A V Okeke, Lynn McKinley-Grant, Susan C Taylor, Seemal R Desai, Tarannum Jaleel, Candrice R Heath, Sewon Kang, Neelam Vashi, ...> ;Journal of the American Academy of Dermatology. 2024 Feb 9
Objective assessment of color match for a universal tinted sunscreen on individuals with skin of color: A pilot study.
Kohli, I., Teklehaimanot, F., Lane, B., Ceresnie, M., Huggins, R., Hamzavi, I., Lim, H., Mohammad, T.> ;Photodermatology, Photoimmunology & Photomedicine. 2024 Jan 1
Evaluation of the protection of sunscreen products against long wavelength ultraviolet A1 and visible light-induced biological effects.
Atyam, A., Kohli, I., Ezekwe, N., Pourang, A., Lyons, A., Narla, S., Zia, S., Friedman, B., Hamzavi, I., Lim, H.> ;Photodermatology, Photoimmunology & Photomedicine. 2024 Jan 1
Practical guidelines for the treatment of vitiligo with the melanocyte-keratinocyte transplantation procedure.
Jenna Yousif, Marissa S Ceresnie, Iltefat H Hamzavi, Tasneem F Mohammad> ;Archives of Dermatological Research. 2023 Dec 1
Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement.
Mastacouris, N., Tannenbaum, R., Strunk, A., Koptyev, J., Aarts, P., Alhusayen, R., Bechara, F., Benhadou, F., Bettoli, V., Brassard, A., Brown, D., Choon, S., Coutts,...> ;JAMA Dermatology. 2023 Nov 1
5 citations
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new mana...
Nanja van Geel, Reinhart Speeckaert, Alain Taïeb, Khaled Ezzedine, Henry W Lim, Amit G Pandya, Thierry Passeron, Albert Wolkerstorfer, Marwa Abdallah, Augustin Alomar,...> ;Journal of the European Academy of Dermatology and Venereology. 2023 Nov 1
Best practices in the treatment of melasma with a focus on patients with skin of color.
Seemal R Desai, Andrew F Alexis, Nada Elbuluk, Pearl E Grimes, Jonathan Weiss, Iltefat H Hamzavi, Susan C Taylor> ;Journal of the American Academy of Dermatology. 2024 Feb 1
6 citations
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment...
Julien Seneschal, Reinhart Speeckaert, Alain Taïeb, Albert Wolkerstorfer, Thierry Passeron, Amit G Pandya, Henry W Lim, Khaled Ezzedine, Youwen Zhou, Flora Xiang, Stev...> ;Journal of the European Academy of Dermatology and Venereology. 2023 Nov 1
Roadmap to VIRTUAL-GLOBAL: coordinating VItiligo RegisTries for adUlts And chiLdren internationally.
Viktoria Eleftheriadou, Iltefat Hamzavi, Jun Min Bae, Khaled Ezzedine> ;The British Journal of Dermatology. 2023 Dec 20
2 citations
Mental Health and Psychosocial Quality-of-Life Burden Among Patients With Vitiligo: Findings From the Global VALIANT Study.
Kristen Bibeau, Khaled Ezzedine, John E Harris, Nanja van Geel, Pearl Grimes, Davinder Parsad, Mukta Tulpule, Jackie Gardner, Yan Valle, Gaone Tlhong Matewa, Christine...> ;JAMA Dermatology. 2023 Oct 1
Clinician-reported outcome measures for the assessment of vitiligo: A scoping review.
Nanja van Geel, Jolien Duponselle, Liesbeth Delbaere, Sandrine Herbelet, Viktoria Eleftheriadou, Khaled Ezzedine, Maxine Forman, Amit Garg, Iltefat H Hamzavi, Julien S...> ;Journal of the European Academy of Dermatology and Venereology. 2023 Nov 1
Assessing the trends of outcome measures and quality of life instruments in vitiligo: A systematic review.
Jalal Maghfour, Rajaa Shoukfeh, Iltefat H Hamzavi, Khaled Ezzedine, Tasneem F Mohammad> ;Journal of the European Academy of Dermatology and Venereology. 2023 Nov 1
A method for assessing rater reliability in applying the Vitiligo Area Scoring Index.
Nishant Kumar, Aunna Pourang, Nneamaka Ezekwe, Angela Parks-Miller, Tasneem F Mohammad, Richard H Huggins, Linda S Deal, Tatjana Lukic, Fan Zhang, Henry W Lim, Iltefat...> ;The British Journal of Dermatology. 2023 Oct 25
1 citations
Optimisation of skin phototype classification.
Sophie S Lim, Tasneem F Mohammad, Indermeet Kohli, Iltefat Hamzavi, Michelle Rodrigues> ;Pigment Cell & Melanoma Research. 2023 Nov 1
2 citations
Exploring the natural and treatment history of vitiligo: perceptions of patients and healthcare professionals from the global VALIANT study.
Iltefat H Hamzavi, Kristen Bibeau, Pearl Grimes, John E Harris, Nanja van Geel, Davinder Parsad, Mukta Tulpule, Jackie Gardner, Yan Valle, Gaone Tlhong Matewa, Christi...> ;The British Journal of Dermatology. 2023 Oct 25
1 citations
Evaluating the efficacy of continuous wave carbon dioxide laser therapy in conjunction with biologics for the management of hidradenitis suppurativa.
Jalal Maghfour, Fiatsogbe Dzuali, Nnemaka Ezekwe, Jacobsen Gordon, Iltefat H Hamzavi> ;The British Journal of Dermatology. 2023 Nov 16
1 citations
Diagnosing Disorders of Hypopigmentation and Depigmentation in Patients with Skin of Color.
Marissa S Ceresnie, Sarah Gonzalez, Iltefat H Hamzavi> ;Dermatologic Clinics. 2023 Jul 1
COVID-19 Infection in Hidradenitis Suppurativa Patients: A Retrospective Study.
Devea R De, Jonathan W Rick, Terri Shih, Jennifer L Hsiao, Iltefat Hamzavi, Vivian Y Shi> ;Skin Appendage Disorders. 2023 Jun 1
Mass cytometry uncovers a distinct peripheral immune profile and upregulated CD38 expression in patients with hidradenitis suppurativa.
Peter Dimitrion, Iltefat Hamzavi, Congcong Yin, Jugmohit Toor, Kalpana Subedi, Namir Khalasawi, Angela Miller, Richard Huggins, Indra Adrianto, Jesse Veenstra, Gautham...> ;Cellular & Molecular Immunology. 2023 Aug 1
Factors associated with disease-specific life impact in patients with hidradenitis suppurativa: results from the Global VOICE project.
Garg, A., Rawal, S., Akilov, O., Alavi, A., Ardon, C., Bechara, F., Cohen, A., Cohen, S., Daveluy, S., Del Marmol, V., Delage, M., Esmann, S., Fisher, S., Giamarellos-...> ;The British Journal of Dermatology. 2023 May 24
Recipient-to-Donor Ratios in the Surgical Treatment of Vitiligo, Leukoderma, and Piebaldism: A Retrospective Review.
Jalal Maghfour, Redina Bardhi, Richard Huggins, Iltefat H Hamzavi, Tasneem F Mohammad> ;Dermatology. 2023 Jan 1
Evaluating the Impact of Exclusion Criteria on the Generalizability of Hidradenitis Suppurativa Treatment Research.
Jalal Maghfour, Vivian Liu, Angela Parks-Miller, Iltefat H Hamzavi> ;JID Innovations. 2023 May 1
1 citations
Implementation of the vitiligo area scoring index in clinical studies of patients with vitiligo: a scoping review.
Marissa S Ceresnie, Elizabeth Warbasse, Sarah Gonzalez, Aunna Pourang, Iltefat H Hamzavi> ;Archives of Dermatological Research. 2023 Oct 1
Expert opinion about laser and intense pulsed light (IPL)-induced leukoderma or vitiligo: a cross-sectional survey study.
Nicoline F Post, Noah X Van Broekhoven, Annelies Lommerts, Jung M Bae, Marcel W Bekkenk, Caio C Silva de Castro, Viktioria Eleftheriadou, Samia Esmat, Khaled Ezzedine,...> ;Archives of Dermatological Research. 2023 Oct 1
Join now to see all

Journal Articles

Surgical Interventions for Patients with Vitiligo
Iltefat Hamzavi, MD, JAMA Dermatology
Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum
Haley B Naik, Iltefat H Hamzavi, Jennifer L Hsiao, JAMA Dermatology

Lectures

Advanced Management Strategies for Hidradenitis Suppurativa
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019

Authored Content

Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and PostpartumMay 2020

Press Mentions

Hottest Topics of the 2023 AAD Annual MeetingMarch 27th, 2023
Ruxolitinib Cream Meets Primary Endpoints in Phase 3 Vitiligo TrialOctober 5th, 2021
UV-C Light Could Kill COVID-19 on N95 MasksSeptember 24th, 2020
Join now to see all